{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "ed465bce-afb5-4955-9a74-e884ce0938eb",
   "metadata": {},
   "source": [
    "# WEB SCRAPING"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "780752d6-ac4c-4870-aff2-f585436251f7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "D:\\OneDrive\\w210\\capstone-project\n"
     ]
    }
   ],
   "source": [
    "%cd ..\n",
    "# %cd media/capstone-project"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "b3e85ca0-23ed-4fa6-8765-c0a8cf73c716",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "from bs4 import BeautifulSoup\n",
    "from collections import OrderedDict\n",
    "import pprint\n",
    "import random\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import itertools\n",
    "import re\n",
    "import time\n",
    "\n",
    "pd.set_option('display.max_rows', None)\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.max_colwidth', 100)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ed9b000f-c41c-4fa3-aec2-0c38f545506e",
   "metadata": {},
   "source": [
    "## Scaping Drug Information From Drugbank.com"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "0586822d-60b6-4c30-b2d7-d53b3f47f486",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of interactions with SMILES: (1847556, 9)\n",
      "Number of distinct drugs: 3032\n",
      "Number of distinct drugs with SMILES: 1704\n",
      "Example of drug ID: ['DB00006', 'DB00014', 'DB00027', 'DB00035', 'DB00080', 'DB00091', 'DB00104', 'DB00115', 'DB00120', 'DB00122']\n"
     ]
    }
   ],
   "source": [
    "# # Extract all unique drug_id from DDIs\n",
    "# ddis = pd.read_csv('data/ddis_from_api_negative_control.csv', sep='\\t')\n",
    "# drugbank_ids = sorted(set(ddis['d1'].unique()) | set(ddis['d2'].unique()))\n",
    "# ddis_smiles = ddis.dropna(subset=['smiles1', 'smiles2'], how='any')\n",
    "# drugbank_ids_smiles = sorted(set(ddis_smiles['d1'].unique()) | set(ddis_smiles['d2'].unique()))\n",
    "# print('Number of interactions with SMILES:', ddis_smiles.shape)\n",
    "# print('Number of distinct drugs:', len(drugbank_ids))\n",
    "# print('Number of distinct drugs with SMILES:', len(drugbank_ids_smiles))\n",
    "# print('Example of drug ID:', drugbank_ids_smiles[:10])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "5336c81d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of distinct drugs with SMILES: 2567\n",
      "Example of drug ID: ['DB00006', 'DB00007', 'DB00014', 'DB00027', 'DB00035', 'DB00067', 'DB00080', 'DB00091', 'DB00115', 'DB00118']\n"
     ]
    }
   ],
   "source": [
    "# All unique_id from web_scraping with SMILES\n",
    "ddis_smiles = pd.read_csv('data/scraping_drug_smiles.csv')\n",
    "ddis_smiles = ddis_smiles[ddis_smiles[\"SMILES\"] != \"Not Available\"]\n",
    "drugbank_ids = sorted(set(ddis_smiles['drug_id'].unique()))\n",
    "print('Number of distinct drugs with SMILES:', len(drugbank_ids))\n",
    "print('Example of drug ID:', drugbank_ids[:10])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "0198af18-6b4c-408a-a782-002e4a7881ab",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "def get_drugbank_information(drugbank_id, verbose=False):\n",
    "    \"\"\"Parse drug detailed information from drugbank.com website\"\"\"\n",
    "    # Initialize\n",
    "    global processed_id\n",
    "\n",
    "    # URL to scrape\n",
    "    url = f\"https://go.drugbank.com/drugs/{drugbank_id}\"\n",
    "\n",
    "    # Send GET request\n",
    "    response = requests.get(url)\n",
    "\n",
    "    if response.status_code == 200:\n",
    "        # parse the content as HTML\n",
    "        try:\n",
    "            soup = BeautifulSoup(response.content, \"html.parser\")\n",
    "            # print(soup.prettify())\n",
    "\n",
    "        except:\n",
    "            print('Could not find drug information for', drugbank_id)\n",
    "            soup = None\n",
    "            processed_id.append(drugbank_id)\n",
    "\n",
    "        if soup:\n",
    "            # Extract each section (dl_element) from card_content\n",
    "            content_container = soup.find('div', class_='content-container')\n",
    "            drug_content = content_container.find('div', class_='drug-content')\n",
    "            drug_card = drug_content.find('div', class_='drug-card')\n",
    "            card_content = drug_card.find('div', class_='card-content')\n",
    "            dl_elements = card_content.find_all('dl')\n",
    "\n",
    "            # Initialize drug_info dict, ensure None value is return if not found\n",
    "            keys = ['drug_id', 'generic_name', 'SMILES', 'drug_summary', 'brand_names', 'type',\n",
    "                    'groups', 'weight', 'chemical_formula', 'synonyms', 'indication',\n",
    "                    'conditions', 'pharmacodynamics', 'mechanism_of_action',\n",
    "                    'target', 'protein_binding','metabolism', 'half_life','clearance',\n",
    "                    'metabolism_pathway', 'action_pathway', 'UNII', 'CAS']\n",
    "            drug_info = OrderedDict.fromkeys(keys)\n",
    "\n",
    "            # Extracting texts\n",
    "            for dl in dl_elements:\n",
    "                # all term elements under each section\n",
    "                dts = dl.find_all('dt')  # all terms, distinguish by id\n",
    "                dds = dl.find_all('dd')  # all definition/texts for each term\n",
    "\n",
    "                # Looping through each term, definition element\n",
    "                for dt, dd in zip(dts, dds):\n",
    "                    try:\n",
    "                        dt_id = dt[\"id\"]\n",
    "                        ## 1. IDENTIFICATION\n",
    "                        # Drug summary\n",
    "                        if dt_id == 'summary':\n",
    "                            drug_info['drug_summary'] = dd.text.strip().replace('\\n', ' ')\n",
    "\n",
    "                        # Brand names\n",
    "                        if dt_id == 'brand-names':\n",
    "                            drug_info['brand_names'] = dd.text.strip().replace('\\n', ', ')\n",
    "\n",
    "                        # Generic name\n",
    "                        if dt_id == 'generic-name':\n",
    "                            drug_info['generic_name'] = dd.text.strip()\n",
    "\n",
    "                        # Drugbank id\n",
    "                        if dt_id == 'drugbank-accession-number':\n",
    "                            drug_info['drug_id'] = dd.text.strip()\n",
    "\n",
    "                        # Drug Type\n",
    "                        if dt_id == 'type':\n",
    "                            drug_info['type'] = dd.text.strip()\n",
    "\n",
    "                        # Group\n",
    "                        if dt_id == 'groups':\n",
    "                            drug_info['groups'] = dd.text.strip().replace('\\n', ', ')\n",
    "\n",
    "                        # Weight\n",
    "                        if dt_id == 'weight':\n",
    "                            drug_info['weight'] = dd.text.strip()\n",
    "\n",
    "                        # Chemical Formula\n",
    "                        if dt_id == 'chemical-formula':\n",
    "                            drug_info['chemical_formula'] = dd.text.strip()\n",
    "\n",
    "                        # Synonyms\n",
    "                        if dt_id == 'synonyms':\n",
    "                            synonyms = []\n",
    "                            li_elements = dd.find_all('li')\n",
    "                            for li in li_elements:\n",
    "                                synonym = li.text.strip()\n",
    "                                synonyms.append(synonym)\n",
    "                            drug_info['synonyms'] = ' | '.join(synonyms)\n",
    "\n",
    "                        ## 2. PHARMACOLOGY\n",
    "                        # Indication\n",
    "                        if dt_id == 'indication':\n",
    "                            drug_info['indication'] = dd.text.strip().replace('\\n', '').replace('â€¢', '.')\n",
    "\n",
    "                        # Associated Conditions\n",
    "                        if dt_id == 'associated-conditions':\n",
    "                            conditions = []\n",
    "                            li_elements = dd.find_all('li')\n",
    "                            for li in li_elements:\n",
    "                                condition = li.text.strip()\n",
    "                                conditions.append(condition)\n",
    "                            drug_info['conditions'] = ' | '.join(conditions)\n",
    "\n",
    "                        # Contraindications\n",
    "                        # if dt_id == 'contraindications-blackbox-warnings':\n",
    "                        #     drug_info['contraindications'] = dd.text \\\n",
    "                        #         .replace('Avoid life-threatening adverse drug events', '') \\\n",
    "                        #         .replace(\n",
    "                        #         'Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.',\n",
    "                        #         '') \\\n",
    "                        #         .replace('Learn more', '') \\\n",
    "                        #         .replace('Avoid life-threatening adverse drug events', '') \\\n",
    "                        #         .replace('& improve clinical decision support.', '').strip()\n",
    "\n",
    "                        # Pharmacodynamics\n",
    "                        if dt_id == 'pharmacodynamics':\n",
    "                            drug_info['pharmacodynamics'] = dd.text.strip().replace('\\n', ' | ')\n",
    "\n",
    "                        # Mechanism of action & target\n",
    "                        if dt_id == 'mechanism-of-action':\n",
    "                            mechanisms = []\n",
    "                            p_mechanism = dd.find_all('p')  # All paragraphs\n",
    "                            for p in p_mechanism:\n",
    "                                mechanism = p.text.strip()\n",
    "                                mechanisms.append(mechanism)\n",
    "                            drug_info['mechanism_of_action'] = ' | '.join(mechanisms).replace('\\n', ' | ')\n",
    "\n",
    "                            # Target\n",
    "                            drug_targets = []\n",
    "                            target_table = dd.find('table')\n",
    "                            target_body = target_table.find('tbody')\n",
    "                            target_protein = target_body.find_all('a')\n",
    "                            target_span = dd.find_all('span')\n",
    "                            target_class = dd.find_all('div')\n",
    "\n",
    "                            for _span, _protein, _class in zip(target_span, target_protein, target_class):\n",
    "                                target_info = f'Category: {_span.text}, Protein: {_protein.text}, Actions: {_class.text}'\n",
    "                                drug_targets.append(target_info)\n",
    "\n",
    "                            drug_info['target'] = ' | '.join(drug_targets)\n",
    "\n",
    "                        # Protein Binding\n",
    "                        if dt_id == 'protein-binding':\n",
    "                            drug_info['protein_binding'] = dd.text.strip().replace('\\n', ' | ')\n",
    "\n",
    "                        # Metabolism\n",
    "                        if dt_id == 'metabolism':\n",
    "                            paragraph = dd.find('p').text.strip()\n",
    "                            metabolite = dd.find('li').text.strip().replace('\\n\\n\\n', ' > ').replace('\\n', ' | ')\n",
    "                            if metabolite :\n",
    "                                paragraph = f'{paragraph} | Metabolite: {metabolite}'\n",
    "                            drug_info['metabolism'] = paragraph\n",
    "\n",
    "                        # Half-life\n",
    "                        if dt_id == 'half-life':\n",
    "                            drug_info['half_life'] = dd.text.strip().replace('\\n', ' | ')\n",
    "\n",
    "                        # Clearance\n",
    "                        if dt_id == 'clearance':\n",
    "                            drug_info['clearance'] = dd.text.strip().replace('\\n', ' | ')\n",
    "\n",
    "                        # Pathways\n",
    "                        if dt_id == 'pathways':\n",
    "                            path_table = dd.find('table')\n",
    "                            if path_table:\n",
    "                                path_body = path_table.find('tbody')\n",
    "                                path_tr = path_body.find_all('tr')\n",
    "                                for each_tr in path_tr:\n",
    "                                    path_td = each_tr.find_all('td')\n",
    "                                    url_link = path_td[0].find(\"a\")[\"href\"]\n",
    "                                    url_category = path_td[1].text\n",
    "                                    # pathway = get_pathway(url_link)\n",
    "                                    if url_category == 'Drug metabolism':\n",
    "                                        drug_info['metabolism_pathway'] = url_link\n",
    "                                    if url_category == 'Drug action':\n",
    "                                        drug_info['action_pathway'] = url_link\n",
    "\n",
    "                        # UNII\n",
    "                        if dt_id == 'unii':\n",
    "                            drug_info['UNII'] = dd.text.strip()\n",
    "\n",
    "                        # CAS\n",
    "                        if dt_id == 'cas-number':\n",
    "                            drug_info['CAS'] = dd.text.strip()\n",
    "\n",
    "                        # SMILES\n",
    "                        if dt_id == 'smiles':\n",
    "                            drug_info['SMILES'] = dd.text.strip()\n",
    "\n",
    "                    except:\n",
    "                        continue\n",
    "\n",
    "            if verbose:\n",
    "                pprint.pprint(drug_info)\n",
    "            processed_id.append(drugbank_id)\n",
    "            return drug_info"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "a732a253-90ec-43dc-86cd-683d5845c83c",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "OrderedDict([('drug_id', 'DB00118'),\n",
      "             ('generic_name', 'Ademetionine'),\n",
      "             ('SMILES',\n",
      "              'C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N'),\n",
      "             ('drug_summary', None),\n",
      "             ('brand_names', None),\n",
      "             ('type', 'Small Molecule'),\n",
      "             ('groups', 'Approved, Investigational, Nutraceutical'),\n",
      "             ('weight', 'Average: 398.44 Monoisotopic: 398.137239006'),\n",
      "             ('chemical_formula', 'C15H22N6O5S'),\n",
      "             ('synonyms',\n",
      "              'Ademetionine | AdoMet | L-S-Adenosylmethionine | '\n",
      "              'S-Adenosylmethionine | SAM | SAM-e | SAMe'),\n",
      "             ('indication',\n",
      "              'S-Adenosylmethionine (SAMe) is used as a drug in Europe for the '\n",
      "              'treatment of depression, liver disorders, fibromyalgia, and '\n",
      "              'osteoarthritis. It has also been introduced into the United '\n",
      "              'States market as a dietary supplement for the support of bone '\n",
      "              'and joint health, as well as mood and emotional well '\n",
      "              'being.Reduce drug development failure ratesBuild, train, & '\n",
      "              'validate machine-learning modelswith evidence-based and '\n",
      "              'structured datasets.See how  Build, train, & validate '\n",
      "              'predictive machine-learning models with structured datasets.See '\n",
      "              'how'),\n",
      "             ('conditions',\n",
      "              'Fatigue | Intrahepatic Cholestasis | Major Depressive Disorder '\n",
      "              '(MDD)'),\n",
      "             ('pharmacodynamics',\n",
      "              'S-adenosylmethionine is an intermediate metabolite of '\n",
      "              'methionine. Its involvement in methylation assists in cellular '\n",
      "              'growth and repair, maintains the phospho-bilipid layer in cell '\n",
      "              'membranes. It also helps in the maintenance of the action of '\n",
      "              'several hormones and neurotransmitters that affect mood. '\n",
      "              'Highest concentration are found in the brain and the liver.'),\n",
      "             ('mechanism_of_action',\n",
      "              'S-Adenosylmethionine (SAMe) is a natural substance present in '\n",
      "              'the cells of the body. It is a direct metabolite of the '\n",
      "              'essential amino acid L-methionine. SAMe plays a crucial '\n",
      "              'biochemical role in the body by donating a one-carbon methyl '\n",
      "              'group in a process called transmethylation. SAMe, formed from '\n",
      "              'the reaction of L-methionine and adenosine triphosphate '\n",
      "              'catalyzed by the enzyme S-adenosylmethionine synthetase, is the '\n",
      "              'methyl-group donor in the biosynthesis of both DNA and RNA '\n",
      "              'nucleic acids, phospholipids, proteins, epinephrine, melatonin, '\n",
      "              'creatine and other molecules.'),\n",
      "             ('target',\n",
      "              'Category: U, Protein: Catechol O-methyltransferase, Actions: '\n",
      "              'cofactor | Category: U, Protein: Cap-specific mRNA '\n",
      "              \"(nucleoside-2'-O-)-methyltransferase 1, Actions: cofactor | \"\n",
      "              'Category: Not Available, Protein: Arsenite methyltransferase, '\n",
      "              'Actions: cofactor | Category: U, Protein: Glycine '\n",
      "              'N-methyltransferase, Actions: cofactor | Category: Not '\n",
      "              'Available, Protein: S-adenosylmethionine decarboxylase '\n",
      "              'proenzyme, Actions: activator | Category: U, Protein: '\n",
      "              'S-adenosylmethionine synthase isoform type-2, Actions: '\n",
      "              'cofactor'),\n",
      "             ('protein_binding', 'Not Available'),\n",
      "             ('metabolism',\n",
      "              'Significant first-pass metabolism in the liver. Approximately '\n",
      "              '50% of S-Adenosylmethionine (SAMe) is metabolized in the liver. '\n",
      "              'SAMe is metabolized to S-adenosylhomocysteine, which is then '\n",
      "              'metabolized to homocysteine. Homocysteine can either be '\n",
      "              'metabolized to cystathionine and then cysteine or to '\n",
      "              'methionine. The cofactor in the metabolism of homocysteine to '\n",
      "              'cysteine is vitamin B6. Cofactors for the metabolism of '\n",
      "              'homocysteine to methionine are folic acid, vitamin B12 and '\n",
      "              'betaine. | Metabolite: Ademetionine > Cystathionine > Cysteine '\n",
      "              '> Methionine > Homocysteine > S-Adenosylhomocysteine'),\n",
      "             ('half_life', 'Not Available'),\n",
      "             ('clearance', 'Not Available'),\n",
      "             ('metabolism_pathway', None),\n",
      "             ('action_pathway',\n",
      "              'http://smpdb.ca/view/SMP0000429?highlight[compounds][]=DB00118&highlight[proteins][]=DB00118'),\n",
      "             ('UNII', '7LP2MPO46S'),\n",
      "             ('CAS', '29908-03-0')])\n"
     ]
    }
   ],
   "source": [
    "# Test scraping function with a drug_id\n",
    "# drugbank_id = 'DB00316'\n",
    "drugbank_id = 'DB00118'\n",
    "processed_id = []\n",
    "drug_info = get_drugbank_information(drugbank_id, verbose=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "05f704de-5df7-4d5b-8743-b2992bd1486b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Scraping 0 to 50 Drug Ids...\n",
      "Scraping 50 to 100 Drug Ids...\n",
      "Scraping 100 to 150 Drug Ids...\n",
      "Scraping 150 to 200 Drug Ids...\n",
      "Scraping 200 to 250 Drug Ids...\n",
      "Scraping 250 to 300 Drug Ids...\n",
      "Scraping 300 to 350 Drug Ids...\n",
      "Scraping 350 to 400 Drug Ids...\n",
      "Scraping 400 to 450 Drug Ids...\n",
      "Scraping 450 to 500 Drug Ids...\n",
      "Scraping 500 to 550 Drug Ids...\n",
      "Scraping 550 to 600 Drug Ids...\n",
      "Scraping 600 to 650 Drug Ids...\n",
      "Scraping 650 to 700 Drug Ids...\n",
      "Scraping 700 to 750 Drug Ids...\n",
      "Scraping 750 to 800 Drug Ids...\n",
      "Scraping 800 to 850 Drug Ids...\n",
      "Scraping 850 to 900 Drug Ids...\n",
      "Scraping 900 to 950 Drug Ids...\n",
      "Scraping 950 to 1000 Drug Ids...\n",
      "Scraping 1000 to 1050 Drug Ids...\n",
      "Scraping 1050 to 1100 Drug Ids...\n",
      "Scraping 1100 to 1150 Drug Ids...\n",
      "Scraping 1150 to 1200 Drug Ids...\n",
      "Scraping 1200 to 1250 Drug Ids...\n",
      "Scraping 1250 to 1300 Drug Ids...\n",
      "Scraping 1300 to 1350 Drug Ids...\n",
      "Scraping 1350 to 1400 Drug Ids...\n",
      "Scraping 1400 to 1450 Drug Ids...\n",
      "Scraping 1450 to 1500 Drug Ids...\n",
      "Scraping 1500 to 1550 Drug Ids...\n",
      "Scraping 1550 to 1600 Drug Ids...\n",
      "Scraping 1600 to 1650 Drug Ids...\n",
      "Scraping 1650 to 1700 Drug Ids...\n",
      "Scraping 1700 to 1750 Drug Ids...\n",
      "Scraping 1750 to 1800 Drug Ids...\n",
      "Scraping 1800 to 1850 Drug Ids...\n",
      "Scraping 1850 to 1900 Drug Ids...\n",
      "Scraping 1900 to 1950 Drug Ids...\n",
      "Scraping 1950 to 2000 Drug Ids...\n",
      "Scraping 2000 to 2050 Drug Ids...\n",
      "Scraping 2050 to 2100 Drug Ids...\n",
      "Scraping 2100 to 2150 Drug Ids...\n",
      "Scraping 2150 to 2200 Drug Ids...\n",
      "Scraping 2200 to 2250 Drug Ids...\n",
      "Scraping 2250 to 2300 Drug Ids...\n",
      "Scraping 2300 to 2350 Drug Ids...\n",
      "Scraping 2350 to 2400 Drug Ids...\n",
      "Scraping 2400 to 2450 Drug Ids...\n",
      "Scraping 2450 to 2500 Drug Ids...\n",
      "Scraping 2500 to 2550 Drug Ids...\n",
      "Scraping 2550 to 2600 Drug Ids...\n"
     ]
    }
   ],
   "source": [
    "# Scraping all drugs from web\n",
    "processed_id = []\n",
    "drug_infos = []\n",
    "\n",
    "i = 0\n",
    "for drugbank_id in drugbank_ids:\n",
    "    if i % 50 == 0:\n",
    "        print(f'Scraping {i} to {i+50} Drug Ids...')\n",
    "    if drugbank_id not in processed_id:\n",
    "        drug_info = get_drugbank_information(drugbank_id)\n",
    "        if drug_info:\n",
    "            drug_infos.append(drug_info)\n",
    "        with open(\"data/drug_info_scraping.txt\", \"a\", encoding='utf8') as f: # Open the file in append mode\n",
    "            f.write(str(drug_info))\n",
    "            f.write(\"\\n\")\n",
    "    i += 1 "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "50d81463-2543-474a-be11-8cebe7357bb5",
   "metadata": {},
   "source": [
    "### EDA"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 133,
   "id": "942d761e-cc1a-48d5-9270-34963a3f13f6",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Drug Information Dimension: (2567, 23)\n",
      "Number of distinct drugs: 2567\n",
      "Number of drugs having SMILES: 2567\n",
      "Number of drugs in Approved group: 2040\n",
      "Number of drugs NOT in Approved group: 527\n",
      "Number of drugs have metabolism pathways: (71, 1)\n",
      "Number of drugs have action pathways: (381, 1)\n",
      "Number of missing values:\n",
      " drug_id                   0\n",
      "generic_name              0\n",
      "SMILES                    0\n",
      "drug_summary            654\n",
      "brand_names            1180\n",
      "type                      0\n",
      "groups                    0\n",
      "weight                    0\n",
      "chemical_formula          0\n",
      "synonyms                  0\n",
      "indication                0\n",
      "conditions              751\n",
      "pharmacodynamics          0\n",
      "mechanism_of_action       0\n",
      "target                  591\n",
      "protein_binding           0\n",
      "metabolism             1730\n",
      "half_life                 0\n",
      "clearance                 0\n",
      "metabolism_pathway     2496\n",
      "action_pathway         2186\n",
      "UNII                      0\n",
      "CAS                       0\n",
      "approved_drug             0\n",
      "dtype: int64\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_id</th>\n",
       "      <th>generic_name</th>\n",
       "      <th>SMILES</th>\n",
       "      <th>drug_summary</th>\n",
       "      <th>brand_names</th>\n",
       "      <th>type</th>\n",
       "      <th>groups</th>\n",
       "      <th>weight</th>\n",
       "      <th>chemical_formula</th>\n",
       "      <th>synonyms</th>\n",
       "      <th>indication</th>\n",
       "      <th>conditions</th>\n",
       "      <th>pharmacodynamics</th>\n",
       "      <th>mechanism_of_action</th>\n",
       "      <th>target</th>\n",
       "      <th>protein_binding</th>\n",
       "      <th>metabolism</th>\n",
       "      <th>half_life</th>\n",
       "      <th>clearance</th>\n",
       "      <th>metabolism_pathway</th>\n",
       "      <th>action_pathway</th>\n",
       "      <th>UNII</th>\n",
       "      <th>CAS</th>\n",
       "      <th>approved_drug</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00006</td>\n",
       "      <td>Bivalirudin</td>\n",
       "      <td>CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C...</td>\n",
       "      <td>Bivalirudin is a direct thrombin inhibitor used to treat heparin-induced thrombocytopenia and to...</td>\n",
       "      <td>Angiomax</td>\n",
       "      <td>Small Molecule</td>\n",
       "      <td>Approved, Investigational</td>\n",
       "      <td>Average: 2180.2853 Monoisotopic: 2178.985813062</td>\n",
       "      <td>C98H138N24O33</td>\n",
       "      <td>Bivalirudin | Bivalirudina | Bivalirudinum</td>\n",
       "      <td>For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivaliru...</td>\n",
       "      <td>Thrombosis</td>\n",
       "      <td>Bivalirudin mediates an inhibitory action on thrombin by directly and specifically binding to bo...</td>\n",
       "      <td>Inhibits the action of thrombin by binding both to its catalytic site and to its anion-binding e...</td>\n",
       "      <td>Category: A, Protein: Prothrombin, Actions: inhibitor</td>\n",
       "      <td>Other than thrombin and red blood cells, bivalirudin does not bind to plasma proteins.</td>\n",
       "      <td>None</td>\n",
       "      <td>Normal renal function: 25 min (in normal conditions) | Creatinine clearance 10-29mL/min: 57min |...</td>\n",
       "      <td>3.4 mL/min/kg [Normal renal function] | 3.4 mL/min/kg [mild renal function] | 2.7 mL/min/kg [mod...</td>\n",
       "      <td>None</td>\n",
       "      <td>http://smpdb.ca/view/SMP0000277?highlight[compounds][]=DB00006&amp;highlight[proteins][]=DB00006</td>\n",
       "      <td>TN9BEX005G</td>\n",
       "      <td>128270-60-0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00007</td>\n",
       "      <td>Leuprolide</td>\n",
       "      <td>CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1...</td>\n",
       "      <td>Leuprolide is a peptide-based GnRH receptor superagonist used for the palliative treatment of pr...</td>\n",
       "      <td>Camcevi, Eligard, Fensolvi, Lupaneta Pack 1-month, Lupron, Lupron Depot-ped, Viadur, Zeulide Depot</td>\n",
       "      <td>Small Molecule</td>\n",
       "      <td>Approved, Investigational</td>\n",
       "      <td>Average: 1209.3983 Monoisotopic: 1208.645462232</td>\n",
       "      <td>C59H84N16O12</td>\n",
       "      <td>Leuprorelin | Leuprorelina | Leuproreline | Leuprorelinum</td>\n",
       "      <td>Leuprolide is indicated for the treatment of advanced prostate cancer 6,12 and as palliative tre...</td>\n",
       "      <td>Advanced Prostate Cancer | Anemia | Central Precocious Puberty (CPP) | Endometriosis</td>\n",
       "      <td>Leuprolide is a gonadotropin-releasing hormone (GnRH) analogue that functions as a GnRH receptor...</td>\n",
       "      <td>Gonadotropin-releasing hormone (GnRH) is a naturally occurring decapeptide that modulates the hy...</td>\n",
       "      <td>Category: A, Protein: Gonadotropin-releasing hormone receptor, Actions: agonist</td>\n",
       "      <td>Leuprolide displays in vitro binding to human plasma proteins between 43% and 49%.5,6,7,8,9,10,12</td>\n",
       "      <td>None</td>\n",
       "      <td>Leuprolide has a terminal elimination half-life of approximately three hours.5,6,7,8,9,10,12</td>\n",
       "      <td>Leuprolide administered as a 1 mg intravenous bolus in healthy males has a mean systemic clearan...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>EFY6W0M8TG</td>\n",
       "      <td>53714-56-0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   drug_id generic_name  \\\n",
       "0  DB00006  Bivalirudin   \n",
       "1  DB00007   Leuprolide   \n",
       "\n",
       "                                                                                                SMILES  \\\n",
       "0  CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C...   \n",
       "1  CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1...   \n",
       "\n",
       "                                                                                          drug_summary  \\\n",
       "0  Bivalirudin is a direct thrombin inhibitor used to treat heparin-induced thrombocytopenia and to...   \n",
       "1  Leuprolide is a peptide-based GnRH receptor superagonist used for the palliative treatment of pr...   \n",
       "\n",
       "                                                                                          brand_names  \\\n",
       "0                                                                                            Angiomax   \n",
       "1  Camcevi, Eligard, Fensolvi, Lupaneta Pack 1-month, Lupron, Lupron Depot-ped, Viadur, Zeulide Depot   \n",
       "\n",
       "             type                     groups  \\\n",
       "0  Small Molecule  Approved, Investigational   \n",
       "1  Small Molecule  Approved, Investigational   \n",
       "\n",
       "                                            weight chemical_formula  \\\n",
       "0  Average: 2180.2853 Monoisotopic: 2178.985813062    C98H138N24O33   \n",
       "1  Average: 1209.3983 Monoisotopic: 1208.645462232     C59H84N16O12   \n",
       "\n",
       "                                                    synonyms  \\\n",
       "0                 Bivalirudin | Bivalirudina | Bivalirudinum   \n",
       "1  Leuprorelin | Leuprorelina | Leuproreline | Leuprorelinum   \n",
       "\n",
       "                                                                                            indication  \\\n",
       "0  For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivaliru...   \n",
       "1  Leuprolide is indicated for the treatment of advanced prostate cancer 6,12 and as palliative tre...   \n",
       "\n",
       "                                                                             conditions  \\\n",
       "0                                                                            Thrombosis   \n",
       "1  Advanced Prostate Cancer | Anemia | Central Precocious Puberty (CPP) | Endometriosis   \n",
       "\n",
       "                                                                                      pharmacodynamics  \\\n",
       "0  Bivalirudin mediates an inhibitory action on thrombin by directly and specifically binding to bo...   \n",
       "1  Leuprolide is a gonadotropin-releasing hormone (GnRH) analogue that functions as a GnRH receptor...   \n",
       "\n",
       "                                                                                   mechanism_of_action  \\\n",
       "0  Inhibits the action of thrombin by binding both to its catalytic site and to its anion-binding e...   \n",
       "1  Gonadotropin-releasing hormone (GnRH) is a naturally occurring decapeptide that modulates the hy...   \n",
       "\n",
       "                                                                            target  \\\n",
       "0                            Category: A, Protein: Prothrombin, Actions: inhibitor   \n",
       "1  Category: A, Protein: Gonadotropin-releasing hormone receptor, Actions: agonist   \n",
       "\n",
       "                                                                                     protein_binding  \\\n",
       "0             Other than thrombin and red blood cells, bivalirudin does not bind to plasma proteins.   \n",
       "1  Leuprolide displays in vitro binding to human plasma proteins between 43% and 49%.5,6,7,8,9,10,12   \n",
       "\n",
       "  metabolism  \\\n",
       "0       None   \n",
       "1       None   \n",
       "\n",
       "                                                                                             half_life  \\\n",
       "0  Normal renal function: 25 min (in normal conditions) | Creatinine clearance 10-29mL/min: 57min |...   \n",
       "1         Leuprolide has a terminal elimination half-life of approximately three hours.5,6,7,8,9,10,12   \n",
       "\n",
       "                                                                                             clearance  \\\n",
       "0  3.4 mL/min/kg [Normal renal function] | 3.4 mL/min/kg [mild renal function] | 2.7 mL/min/kg [mod...   \n",
       "1  Leuprolide administered as a 1 mg intravenous bolus in healthy males has a mean systemic clearan...   \n",
       "\n",
       "  metabolism_pathway  \\\n",
       "0               None   \n",
       "1               None   \n",
       "\n",
       "                                                                                 action_pathway  \\\n",
       "0  http://smpdb.ca/view/SMP0000277?highlight[compounds][]=DB00006&highlight[proteins][]=DB00006   \n",
       "1                                                                                          None   \n",
       "\n",
       "         UNII          CAS  approved_drug  \n",
       "0  TN9BEX005G  128270-60-0              1  \n",
       "1  EFY6W0M8TG   53714-56-0              1  "
      ]
     },
     "execution_count": 133,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_info_df = pd.DataFrame(drug_infos)\n",
    "\n",
    "print('Drug Information Dimension:', drug_info_df.shape)\n",
    "print('Number of distinct drugs:', len(drug_info_df['drug_id'].unique()))\n",
    "print('Number of drugs having SMILES:', len(drug_info_df['SMILES'].unique()))\n",
    "\n",
    "approved_drugs = drug_info_df[drug_info_df['groups'].str.contains('Approved')]\n",
    "not_approved_drugs = drug_info_df[~drug_info_df['groups'].str.contains('Approved')]\n",
    "print('Number of drugs in Approved group:', approved_drugs.shape[0])\n",
    "print('Number of drugs NOT in Approved group:', not_approved_drugs.shape[0])\n",
    "\n",
    "# Create a new column for Approved Drugs\n",
    "drug_info_df[\"approved_drug\"] = np.where(drug_info_df['groups'].str.contains('Approved'), 1, 0)\n",
    "\n",
    "# Count the number of drugs have pathways:\n",
    "metabolism_pathways = drug_info_df[~drug_info_df[\"metabolism_pathway\"].isnull()][[\"metabolism_pathway\"]]\n",
    "action_pathways = drug_info_df[~drug_info_df[\"action_pathway\"].isnull()][[\"action_pathway\"]]\n",
    "print(\"Number of drugs have metabolism pathways:\", metabolism_pathways.shape)\n",
    "print(\"Number of drugs have action pathways:\", action_pathways.shape)\n",
    "print('Number of missing values:\\n', drug_info_df.isnull().sum())\n",
    "\n",
    "# print(drug_info_df['groups'].value_counts())\n",
    "drug_info_df.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 134,
   "id": "c4b6ae83-61ff-4bdb-a8e0-8040b155a3c2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x432 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data = [approved_drugs.shape[0], not_approved_drugs.shape[0]]\n",
    "labels = ['Approved', 'Others']\n",
    "\n",
    "\n",
    "def func(pct, allvals):                    \n",
    "    absolute = int(pct/100.*np.sum(allvals))\n",
    "    return \"{:.1f}%\\n({:,})\".format(pct, absolute)\n",
    "\n",
    "\n",
    "fig, ax = plt.subplots(figsize=(10, 6), subplot_kw=dict(aspect=\"equal\"))\n",
    "wedges, texts, autotexts = ax.pie(data, \n",
    "                                  autopct=lambda pct: func(pct, data),\n",
    "                                  textprops=dict(color=\"w\"),\n",
    "                                  explode=(0.03, 0),\n",
    "                                  colors=['royalblue', 'lightsteelblue'],\n",
    "                                  startangle=90\n",
    "                                 )\n",
    "ax.legend(wedges, labels,\n",
    "          title=\"Group Type\",\n",
    "          loc=\"lower center\",\n",
    "          bbox_to_anchor=(0.25, -0.1, 0.5, 1))\n",
    "\n",
    "plt.setp(autotexts, size=12, weight=\"bold\")\n",
    "ax.set_title(\"Approved Drug Ratio\", fontsize=16, y=0.95)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 135,
   "id": "1240f46f-fc8b-4011-b8d2-5beac22efd68",
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_info_df[\"mechanism_of_action\"] = np.where(drug_info_df[\"mechanism_of_action\"].isin([\"\", \"N/A\", \"not available\"]),\n",
    "                                               'Not Available', drug_info_df[\"mechanism_of_action\"])\n",
    "drug_info_df[\"target\"] = np.where(drug_info_df[\"target\"].isin([\"\", \"N/A\", \"not available\"]),\n",
    "                                               'Not Available', drug_info_df[\"target\"])\n",
    "drug_info_df[\"clearance\"] = np.where(drug_info_df[\"clearance\"].isin([\"\", \"N/A\", \"not available\"]),\n",
    "                                               'clearance', drug_info_df[\"target\"])\n",
    "\n",
    "# Replace missing values with \"Not Available\"\n",
    "drug_info_df = drug_info_df.fillna(\"Not Available\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "id": "301e39af-feef-458b-ae8c-be448577a73d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_id</th>\n",
       "      <th>generic_name</th>\n",
       "      <th>SMILES</th>\n",
       "      <th>drug_summary</th>\n",
       "      <th>brand_names</th>\n",
       "      <th>type</th>\n",
       "      <th>groups</th>\n",
       "      <th>weight</th>\n",
       "      <th>chemical_formula</th>\n",
       "      <th>synonyms</th>\n",
       "      <th>indication</th>\n",
       "      <th>conditions</th>\n",
       "      <th>pharmacodynamics</th>\n",
       "      <th>mechanism_of_action</th>\n",
       "      <th>target</th>\n",
       "      <th>protein_binding</th>\n",
       "      <th>metabolism</th>\n",
       "      <th>half_life</th>\n",
       "      <th>clearance</th>\n",
       "      <th>metabolism_pathway</th>\n",
       "      <th>action_pathway</th>\n",
       "      <th>UNII</th>\n",
       "      <th>CAS</th>\n",
       "      <th>approved_drug</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00006</td>\n",
       "      <td>Bivalirudin</td>\n",
       "      <td>CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C...</td>\n",
       "      <td>Bivalirudin is a direct thrombin inhibitor used to treat heparin-induced thrombocytopenia and to...</td>\n",
       "      <td>Angiomax</td>\n",
       "      <td>Small Molecule</td>\n",
       "      <td>Approved, Investigational</td>\n",
       "      <td>Average: 2180.2853 Monoisotopic: 2178.985813062</td>\n",
       "      <td>C98H138N24O33</td>\n",
       "      <td>Bivalirudin | Bivalirudina | Bivalirudinum</td>\n",
       "      <td>For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivaliru...</td>\n",
       "      <td>Thrombosis</td>\n",
       "      <td>Bivalirudin mediates an inhibitory action on thrombin by directly and specifically binding to bo...</td>\n",
       "      <td>Inhibits the action of thrombin by binding both to its catalytic site and to its anion-binding e...</td>\n",
       "      <td>Category: A, Protein: Prothrombin, Actions: inhibitor</td>\n",
       "      <td>Other than thrombin and red blood cells, bivalirudin does not bind to plasma proteins.</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Normal renal function: 25 min (in normal conditions) | Creatinine clearance 10-29mL/min: 57min |...</td>\n",
       "      <td>Category: A, Protein: Prothrombin, Actions: inhibitor</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>http://smpdb.ca/view/SMP0000277?highlight[compounds][]=DB00006&amp;highlight[proteins][]=DB00006</td>\n",
       "      <td>TN9BEX005G</td>\n",
       "      <td>128270-60-0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00007</td>\n",
       "      <td>Leuprolide</td>\n",
       "      <td>CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1...</td>\n",
       "      <td>Leuprolide is a peptide-based GnRH receptor superagonist used for the palliative treatment of pr...</td>\n",
       "      <td>Camcevi, Eligard, Fensolvi, Lupaneta Pack 1-month, Lupron, Lupron Depot-ped, Viadur, Zeulide Depot</td>\n",
       "      <td>Small Molecule</td>\n",
       "      <td>Approved, Investigational</td>\n",
       "      <td>Average: 1209.3983 Monoisotopic: 1208.645462232</td>\n",
       "      <td>C59H84N16O12</td>\n",
       "      <td>Leuprorelin | Leuprorelina | Leuproreline | Leuprorelinum</td>\n",
       "      <td>Leuprolide is indicated for the treatment of advanced prostate cancer 6,12 and as palliative tre...</td>\n",
       "      <td>Advanced Prostate Cancer | Anemia | Central Precocious Puberty (CPP) | Endometriosis</td>\n",
       "      <td>Leuprolide is a gonadotropin-releasing hormone (GnRH) analogue that functions as a GnRH receptor...</td>\n",
       "      <td>Gonadotropin-releasing hormone (GnRH) is a naturally occurring decapeptide that modulates the hy...</td>\n",
       "      <td>Category: A, Protein: Gonadotropin-releasing hormone receptor, Actions: agonist</td>\n",
       "      <td>Leuprolide displays in vitro binding to human plasma proteins between 43% and 49%.5,6,7,8,9,10,12</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Leuprolide has a terminal elimination half-life of approximately three hours.5,6,7,8,9,10,12</td>\n",
       "      <td>Category: A, Protein: Gonadotropin-releasing hormone receptor, Actions: agonist</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>EFY6W0M8TG</td>\n",
       "      <td>53714-56-0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   drug_id generic_name  \\\n",
       "0  DB00006  Bivalirudin   \n",
       "1  DB00007   Leuprolide   \n",
       "\n",
       "                                                                                                SMILES  \\\n",
       "0  CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C...   \n",
       "1  CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1...   \n",
       "\n",
       "                                                                                          drug_summary  \\\n",
       "0  Bivalirudin is a direct thrombin inhibitor used to treat heparin-induced thrombocytopenia and to...   \n",
       "1  Leuprolide is a peptide-based GnRH receptor superagonist used for the palliative treatment of pr...   \n",
       "\n",
       "                                                                                          brand_names  \\\n",
       "0                                                                                            Angiomax   \n",
       "1  Camcevi, Eligard, Fensolvi, Lupaneta Pack 1-month, Lupron, Lupron Depot-ped, Viadur, Zeulide Depot   \n",
       "\n",
       "             type                     groups  \\\n",
       "0  Small Molecule  Approved, Investigational   \n",
       "1  Small Molecule  Approved, Investigational   \n",
       "\n",
       "                                            weight chemical_formula  \\\n",
       "0  Average: 2180.2853 Monoisotopic: 2178.985813062    C98H138N24O33   \n",
       "1  Average: 1209.3983 Monoisotopic: 1208.645462232     C59H84N16O12   \n",
       "\n",
       "                                                    synonyms  \\\n",
       "0                 Bivalirudin | Bivalirudina | Bivalirudinum   \n",
       "1  Leuprorelin | Leuprorelina | Leuproreline | Leuprorelinum   \n",
       "\n",
       "                                                                                            indication  \\\n",
       "0  For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivaliru...   \n",
       "1  Leuprolide is indicated for the treatment of advanced prostate cancer 6,12 and as palliative tre...   \n",
       "\n",
       "                                                                             conditions  \\\n",
       "0                                                                            Thrombosis   \n",
       "1  Advanced Prostate Cancer | Anemia | Central Precocious Puberty (CPP) | Endometriosis   \n",
       "\n",
       "                                                                                      pharmacodynamics  \\\n",
       "0  Bivalirudin mediates an inhibitory action on thrombin by directly and specifically binding to bo...   \n",
       "1  Leuprolide is a gonadotropin-releasing hormone (GnRH) analogue that functions as a GnRH receptor...   \n",
       "\n",
       "                                                                                   mechanism_of_action  \\\n",
       "0  Inhibits the action of thrombin by binding both to its catalytic site and to its anion-binding e...   \n",
       "1  Gonadotropin-releasing hormone (GnRH) is a naturally occurring decapeptide that modulates the hy...   \n",
       "\n",
       "                                                                            target  \\\n",
       "0                            Category: A, Protein: Prothrombin, Actions: inhibitor   \n",
       "1  Category: A, Protein: Gonadotropin-releasing hormone receptor, Actions: agonist   \n",
       "\n",
       "                                                                                     protein_binding  \\\n",
       "0             Other than thrombin and red blood cells, bivalirudin does not bind to plasma proteins.   \n",
       "1  Leuprolide displays in vitro binding to human plasma proteins between 43% and 49%.5,6,7,8,9,10,12   \n",
       "\n",
       "      metabolism  \\\n",
       "0  Not Available   \n",
       "1  Not Available   \n",
       "\n",
       "                                                                                             half_life  \\\n",
       "0  Normal renal function: 25 min (in normal conditions) | Creatinine clearance 10-29mL/min: 57min |...   \n",
       "1         Leuprolide has a terminal elimination half-life of approximately three hours.5,6,7,8,9,10,12   \n",
       "\n",
       "                                                                         clearance  \\\n",
       "0                            Category: A, Protein: Prothrombin, Actions: inhibitor   \n",
       "1  Category: A, Protein: Gonadotropin-releasing hormone receptor, Actions: agonist   \n",
       "\n",
       "  metabolism_pathway  \\\n",
       "0      Not Available   \n",
       "1      Not Available   \n",
       "\n",
       "                                                                                 action_pathway  \\\n",
       "0  http://smpdb.ca/view/SMP0000277?highlight[compounds][]=DB00006&highlight[proteins][]=DB00006   \n",
       "1                                                                                 Not Available   \n",
       "\n",
       "         UNII          CAS  approved_drug  \n",
       "0  TN9BEX005G  128270-60-0              1  \n",
       "1  EFY6W0M8TG   53714-56-0              1  "
      ]
     },
     "execution_count": 141,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Save data to csv\n",
    "drug_info_df.to_csv('data/scraping_drug_info.csv', index=False, sep='\\t')\n",
    "drug_info_df.to_csv(\"data/scraping_drug_info.txt\", index=False, sep='\\t')\n",
    "\n",
    "# Read data\n",
    "# drug_info_df = pd.read_csv('data/scraping_drug_info.csv', delimiter='\\t')\n",
    "drug_info_df.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 136,
   "id": "7cbf664f-ba5a-4b6c-9da8-f779c55311d9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x432 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# EDA \n",
    "# Calculate word counts\n",
    "def tokenize(x):\n",
    "    if x:\n",
    "        return len(x.split(' '))\n",
    "    else:\n",
    "        return 0\n",
    "\n",
    "df = drug_info_df.copy()\n",
    "df['word_count_indication'] = df['indication'].apply(tokenize)\n",
    "df['word_count_conditions'] = df['conditions'].apply(tokenize)\n",
    "df['word_count_target'] = df['target'].apply(tokenize)\n",
    "df['word_count_protein'] = df['protein_binding'].apply(tokenize)\n",
    "\n",
    "### Plot the word-count distribution for the toxic texts and the non toxic texts.\n",
    "fig, ax = plt.subplots(figsize=(10, 6))\n",
    "sns.set_style('white')\n",
    "\n",
    "# calculate the bin size based on the range of the data\n",
    "bins = range(min(df['word_count_indication'].min(), df['word_count_conditions'].min()), \n",
    "             max(df['word_count_indication'].max(), df['word_count_conditions'].max()) + 2, 2)\n",
    "\n",
    "# plot the histograms with the same bin size\n",
    "sns.histplot(data=df[df[\"indication\"] != \"Not Available\"], x='word_count_indication', label='Indication', bins=bins, color='#4285F4', alpha=0.6)\n",
    "sns.histplot(data=df[df[\"conditions\"] != \"Not Available\"], x='word_count_conditions', label='Conditions', bins=bins, color='#FDB515', alpha=0.6)\n",
    "sns.histplot(data=df[df[\"target\"] != \"Not Available\"], x='word_count_target', label='Target', bins=bins, color='#F44336', alpha=0.6)\n",
    "sns.histplot(data=df[df[\"protein_binding\"] != \"Not Available\"], x='word_count_protein', label='Protein Binding', bins=bins, color='#8BC34A', alpha=0.6)\n",
    "\n",
    "# set the axis labels and title\n",
    "ax.set_xlabel('Text Length', fontsize=14)\n",
    "ax.set_ylabel('Number of Drugs', fontsize=14)\n",
    "ax.set_title('Word Count Distribution', fontsize=16)\n",
    "ax.set_xlim(0, 100)\n",
    "\n",
    "# set the legend and adjust its position\n",
    "plt.legend(loc='upper right', fontsize=12)\n",
    "\n",
    "# set the ticks fontsize\n",
    "ax.tick_params(axis='both', which='major', labelsize=14)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 137,
   "id": "0d489464-6b7c-47a6-ab66-d2c3879b92c5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Feature</th>\n",
       "      <th>Available Data</th>\n",
       "      <th>Missing Data</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>SMILES</td>\n",
       "      <td>2567</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>drug_summary</td>\n",
       "      <td>1913</td>\n",
       "      <td>654</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>groups</td>\n",
       "      <td>2567</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>mechanism_of_action</td>\n",
       "      <td>2031</td>\n",
       "      <td>536</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>target</td>\n",
       "      <td>1852</td>\n",
       "      <td>715</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>protein_binding</td>\n",
       "      <td>1440</td>\n",
       "      <td>1127</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>metabolism</td>\n",
       "      <td>837</td>\n",
       "      <td>1730</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>metabolism_pathway</td>\n",
       "      <td>71</td>\n",
       "      <td>2496</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>action_pathway</td>\n",
       "      <td>381</td>\n",
       "      <td>2186</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>half_life</td>\n",
       "      <td>1632</td>\n",
       "      <td>935</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>clearance</td>\n",
       "      <td>1852</td>\n",
       "      <td>715</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>indication</td>\n",
       "      <td>2567</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>conditions</td>\n",
       "      <td>1816</td>\n",
       "      <td>751</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>pharmacodynamics</td>\n",
       "      <td>1924</td>\n",
       "      <td>643</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                Feature  Available Data  Missing Data\n",
       "0                SMILES            2567             0\n",
       "1          drug_summary            1913           654\n",
       "2                groups            2567             0\n",
       "3   mechanism_of_action            2031           536\n",
       "4                target            1852           715\n",
       "5       protein_binding            1440          1127\n",
       "6            metabolism             837          1730\n",
       "7    metabolism_pathway              71          2496\n",
       "8        action_pathway             381          2186\n",
       "9             half_life            1632           935\n",
       "10            clearance            1852           715\n",
       "11           indication            2567             0\n",
       "12           conditions            1816           751\n",
       "13     pharmacodynamics            1924           643"
      ]
     },
     "execution_count": 137,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Count number of drugs have \"Not Available\" data\n",
    "def count_na_distribution(df, column):\n",
    "    not_avail = df[df[column].isin(['Not Available', 'not available'])].shape[0]\n",
    "    available = df.shape[0] - not_avail\n",
    "    return column, available, not_avail\n",
    "\n",
    "# Extract the Missing Values/ Not Available for some important drug features\n",
    "data_distributions = []\n",
    "features = [\"SMILES\", \"drug_summary\", \"groups\", \"mechanism_of_action\",\n",
    "            \"target\", \"protein_binding\", \"metabolism\", \"metabolism_pathway\",\n",
    "            \"action_pathway\", \"half_life\", \"clearance\", \"indication\", \n",
    "            \"conditions\", \"pharmacodynamics\"]\n",
    "for column in features:\n",
    "    data_count = count_na_distribution(drug_info_df, column)\n",
    "    data_distributions.append(data_count)\n",
    "    \n",
    "# Create a dataframe from the list with column names\n",
    "df_distribution = pd.DataFrame(data_distributions, columns=['Feature', 'Available Data', 'Missing Data'])\n",
    "df_distribution "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 138,
   "id": "e60eb8a7-dd37-411c-b3a6-f0f88283eea7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x432 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Create a stacked horizontal bar chart using seaborn barplot\n",
    "fig, ax = plt.subplots(figsize=(10, 6))\n",
    "sns.set_style('white')\n",
    "# sns.set_theme(style=\"white\")\n",
    "sns.barplot(x=\"Available Data\", y=\"Feature\", data=df_distribution, label=\"Available Data\", color='#4285F4')\n",
    "sns.barplot(x=\"Missing Data\", y=\"Feature\", data=df_distribution, left=df_distribution[\"Available Data\"], label=\"Missing Data\", color=\"lightsteelblue\")\n",
    "\n",
    "# Add title and labels\n",
    "plt.title('Drug Features Data Distribution', fontsize=16)\n",
    "plt.xlabel('Number of Drugs', fontsize=12)\n",
    "plt.ylabel(None)\n",
    "plt.legend(loc=\"lower center\", fontsize=12,\n",
    "          bbox_to_anchor=(0.25, -0.27, 0.5, 1))\n",
    "\n",
    "# Add legend\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "id": "b16b8bb6-5e17-476d-8ac7-9cef5dbdde93",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Feature</th>\n",
       "      <th>Median Length</th>\n",
       "      <th>Min Length</th>\n",
       "      <th>Max Length</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>SMILES</td>\n",
       "      <td>51</td>\n",
       "      <td>2</td>\n",
       "      <td>748</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>drug_summary</td>\n",
       "      <td>128</td>\n",
       "      <td>36</td>\n",
       "      <td>313</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>groups</td>\n",
       "      <td>17</td>\n",
       "      <td>7</td>\n",
       "      <td>54</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>mechanism_of_action</td>\n",
       "      <td>599</td>\n",
       "      <td>39</td>\n",
       "      <td>6926</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>target</td>\n",
       "      <td>147</td>\n",
       "      <td>41</td>\n",
       "      <td>24879</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>protein_binding</td>\n",
       "      <td>67</td>\n",
       "      <td>2</td>\n",
       "      <td>1099</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>metabolism</td>\n",
       "      <td>443</td>\n",
       "      <td>45</td>\n",
       "      <td>2296</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>metabolism_pathway</td>\n",
       "      <td>92</td>\n",
       "      <td>92</td>\n",
       "      <td>92</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>action_pathway</td>\n",
       "      <td>92</td>\n",
       "      <td>92</td>\n",
       "      <td>92</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>half_life</td>\n",
       "      <td>72</td>\n",
       "      <td>2</td>\n",
       "      <td>1026</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>clearance</td>\n",
       "      <td>146</td>\n",
       "      <td>9</td>\n",
       "      <td>24879</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>indication</td>\n",
       "      <td>372</td>\n",
       "      <td>243</td>\n",
       "      <td>3608</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>conditions</td>\n",
       "      <td>73</td>\n",
       "      <td>4</td>\n",
       "      <td>2930</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>pharmacodynamics</td>\n",
       "      <td>522</td>\n",
       "      <td>6</td>\n",
       "      <td>9243</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                Feature  Median Length  Min Length  Max Length\n",
       "0                SMILES             51           2         748\n",
       "1          drug_summary            128          36         313\n",
       "2                groups             17           7          54\n",
       "3   mechanism_of_action            599          39        6926\n",
       "4                target            147          41       24879\n",
       "5       protein_binding             67           2        1099\n",
       "6            metabolism            443          45        2296\n",
       "7    metabolism_pathway             92          92          92\n",
       "8        action_pathway             92          92          92\n",
       "9             half_life             72           2        1026\n",
       "10            clearance            146           9       24879\n",
       "11           indication            372         243        3608\n",
       "12           conditions             73           4        2930\n",
       "13     pharmacodynamics            522           6        9243"
      ]
     },
     "execution_count": 139,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Count the max & mean word counts for the features\n",
    "def word_count(df, column):\n",
    "    available_df = df[~df[column].isin(['Not Available', 'not available'])]\n",
    "    min_length = available_df[column].str.len().min()\n",
    "    max_length = available_df[column].str.len().max()\n",
    "    avg_length = round(available_df[column].str.len().median())\n",
    "    # available = df.shape[0] - not_avail\n",
    "    return column, avg_length, min_length, max_length\n",
    "\n",
    "# Test word_count\n",
    "# word_count(df, \"drug_summary\")\n",
    "\n",
    "wordcount_distributions = []\n",
    "for column in features:\n",
    "    _count = word_count(drug_info_df, column)\n",
    "    wordcount_distributions.append(_count)\n",
    "    \n",
    "# Create a dataframe from the list with column names\n",
    "df_word_count = pd.DataFrame(wordcount_distributions, columns=['Feature', 'Median Length', 'Min Length', 'Max Length'])\n",
    "df_word_count"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "id": "723682da-376f-4034-8bb0-b6121c087557",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_id</th>\n",
       "      <th>generic_name</th>\n",
       "      <th>SMILES</th>\n",
       "      <th>drug_summary</th>\n",
       "      <th>brand_names</th>\n",
       "      <th>type</th>\n",
       "      <th>groups</th>\n",
       "      <th>weight</th>\n",
       "      <th>chemical_formula</th>\n",
       "      <th>synonyms</th>\n",
       "      <th>indication</th>\n",
       "      <th>conditions</th>\n",
       "      <th>pharmacodynamics</th>\n",
       "      <th>mechanism_of_action</th>\n",
       "      <th>target</th>\n",
       "      <th>protein_binding</th>\n",
       "      <th>metabolism</th>\n",
       "      <th>half_life</th>\n",
       "      <th>clearance</th>\n",
       "      <th>metabolism_pathway</th>\n",
       "      <th>action_pathway</th>\n",
       "      <th>UNII</th>\n",
       "      <th>CAS</th>\n",
       "      <th>approved_drug</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1894</th>\n",
       "      <td>DB11091</td>\n",
       "      <td>Hydrogen peroxide</td>\n",
       "      <td>OO</td>\n",
       "      <td>Hydrogen peroxide is a compound used as a disinfectant and sterilizer.</td>\n",
       "      <td>Eskata, Orajel Mouth Sore Rinse</td>\n",
       "      <td>Small Molecule</td>\n",
       "      <td>Approved, Vet approved</td>\n",
       "      <td>Average: 34.0147 Monoisotopic: 34.005479308</td>\n",
       "      <td>H2O2</td>\n",
       "      <td>Hydrogen peroxide</td>\n",
       "      <td>Indicated to be used as a disinfectant and sterilizer. Reduce drug development failure ratesBuil...</td>\n",
       "      <td>Ear infection bacterial | Seborrheic Keratosis (SK) | Impacted ear wax | Superficial skin infect...</td>\n",
       "      <td>Hydrogen peroxide exhibits antimicrobial properties against most forms of microorganisms, includ...</td>\n",
       "      <td>The production of free hydroxyl radicals in the Fenton reaction is thought to be the basis of bi...</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Hydrogen peroxide is reduced by glutathione peroxidase, which is an endogenous enzyme in human t...</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>BBX060AN9V</td>\n",
       "      <td>7722-84-1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      drug_id       generic_name SMILES  \\\n",
       "1894  DB11091  Hydrogen peroxide     OO   \n",
       "\n",
       "                                                                drug_summary  \\\n",
       "1894  Hydrogen peroxide is a compound used as a disinfectant and sterilizer.   \n",
       "\n",
       "                          brand_names            type                  groups  \\\n",
       "1894  Eskata, Orajel Mouth Sore Rinse  Small Molecule  Approved, Vet approved   \n",
       "\n",
       "                                           weight chemical_formula  \\\n",
       "1894  Average: 34.0147 Monoisotopic: 34.005479308             H2O2   \n",
       "\n",
       "               synonyms  \\\n",
       "1894  Hydrogen peroxide   \n",
       "\n",
       "                                                                                               indication  \\\n",
       "1894  Indicated to be used as a disinfectant and sterilizer. Reduce drug development failure ratesBuil...   \n",
       "\n",
       "                                                                                               conditions  \\\n",
       "1894  Ear infection bacterial | Seborrheic Keratosis (SK) | Impacted ear wax | Superficial skin infect...   \n",
       "\n",
       "                                                                                         pharmacodynamics  \\\n",
       "1894  Hydrogen peroxide exhibits antimicrobial properties against most forms of microorganisms, includ...   \n",
       "\n",
       "                                                                                      mechanism_of_action  \\\n",
       "1894  The production of free hydroxyl radicals in the Fenton reaction is thought to be the basis of bi...   \n",
       "\n",
       "             target protein_binding  \\\n",
       "1894  Not Available   Not Available   \n",
       "\n",
       "                                                                                               metabolism  \\\n",
       "1894  Hydrogen peroxide is reduced by glutathione peroxidase, which is an endogenous enzyme in human t...   \n",
       "\n",
       "          half_life      clearance metabolism_pathway action_pathway  \\\n",
       "1894  Not Available  Not Available      Not Available  Not Available   \n",
       "\n",
       "            UNII        CAS  approved_drug  \n",
       "1894  BBX060AN9V  7722-84-1              1  "
      ]
     },
     "execution_count": 140,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_info_df[drug_info_df['SMILES'].str.len() == 2].head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 142,
   "id": "e84956a8-44a2-4d32-b3be-aeaf4b677f8a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_id</th>\n",
       "      <th>generic_name</th>\n",
       "      <th>SMILES</th>\n",
       "      <th>drug_summary</th>\n",
       "      <th>brand_names</th>\n",
       "      <th>type</th>\n",
       "      <th>groups</th>\n",
       "      <th>weight</th>\n",
       "      <th>chemical_formula</th>\n",
       "      <th>synonyms</th>\n",
       "      <th>indication</th>\n",
       "      <th>conditions</th>\n",
       "      <th>pharmacodynamics</th>\n",
       "      <th>mechanism_of_action</th>\n",
       "      <th>target</th>\n",
       "      <th>protein_binding</th>\n",
       "      <th>metabolism</th>\n",
       "      <th>half_life</th>\n",
       "      <th>clearance</th>\n",
       "      <th>metabolism_pathway</th>\n",
       "      <th>action_pathway</th>\n",
       "      <th>UNII</th>\n",
       "      <th>CAS</th>\n",
       "      <th>approved_drug</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2083</th>\n",
       "      <td>DB12010</td>\n",
       "      <td>Fostamatinib</td>\n",
       "      <td>COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC</td>\n",
       "      <td>Fostamatinib is a spleen tyrosine kinase inhibitor used to treat chronic immune thrombocytopenia...</td>\n",
       "      <td>Tavalisse</td>\n",
       "      <td>Small Molecule</td>\n",
       "      <td>Approved, Investigational</td>\n",
       "      <td>Average: 580.4595 Monoisotopic: 580.148291177</td>\n",
       "      <td>C23H26FN6O9P</td>\n",
       "      <td>Fostamatinib</td>\n",
       "      <td>Fostamatinib is indicated for use in the treatment of chronic immune thrombocytopenia (ITP) in p...</td>\n",
       "      <td>Chronic immune thrombocytopenia</td>\n",
       "      <td>The active metabolite of fostamatinib, R406, inhibits signal transduction by Fcγ receptors invol...</td>\n",
       "      <td>The active metabolite of fostamatinib, R406, is an inhibitor of spleen tyrosine kinase (Syk) 2. ...</td>\n",
       "      <td>Category: A, Protein: Tyrosine-protein kinase SYK, Actions: inhibitor | Category: U, Protein: Ad...</td>\n",
       "      <td>R406 is 98.3% bound to plasma proteins Label.</td>\n",
       "      <td>Fostamatinib is metabolized in the gut by alkaline phosphatase to the active metabolite R406 Lab...</td>\n",
       "      <td>R406 has a half-life of elimination of approximately 15 h 6,Label.</td>\n",
       "      <td>Category: A, Protein: Tyrosine-protein kinase SYK, Actions: inhibitor | Category: U, Protein: Ad...</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>Not Available</td>\n",
       "      <td>SQ8A3S5101</td>\n",
       "      <td>901119-35-5</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      drug_id  generic_name  \\\n",
       "2083  DB12010  Fostamatinib   \n",
       "\n",
       "                                                                               SMILES  \\\n",
       "2083  COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC   \n",
       "\n",
       "                                                                                             drug_summary  \\\n",
       "2083  Fostamatinib is a spleen tyrosine kinase inhibitor used to treat chronic immune thrombocytopenia...   \n",
       "\n",
       "     brand_names            type                     groups  \\\n",
       "2083   Tavalisse  Small Molecule  Approved, Investigational   \n",
       "\n",
       "                                             weight chemical_formula  \\\n",
       "2083  Average: 580.4595 Monoisotopic: 580.148291177     C23H26FN6O9P   \n",
       "\n",
       "          synonyms  \\\n",
       "2083  Fostamatinib   \n",
       "\n",
       "                                                                                               indication  \\\n",
       "2083  Fostamatinib is indicated for use in the treatment of chronic immune thrombocytopenia (ITP) in p...   \n",
       "\n",
       "                           conditions  \\\n",
       "2083  Chronic immune thrombocytopenia   \n",
       "\n",
       "                                                                                         pharmacodynamics  \\\n",
       "2083  The active metabolite of fostamatinib, R406, inhibits signal transduction by Fcγ receptors invol...   \n",
       "\n",
       "                                                                                      mechanism_of_action  \\\n",
       "2083  The active metabolite of fostamatinib, R406, is an inhibitor of spleen tyrosine kinase (Syk) 2. ...   \n",
       "\n",
       "                                                                                                   target  \\\n",
       "2083  Category: A, Protein: Tyrosine-protein kinase SYK, Actions: inhibitor | Category: U, Protein: Ad...   \n",
       "\n",
       "                                    protein_binding  \\\n",
       "2083  R406 is 98.3% bound to plasma proteins Label.   \n",
       "\n",
       "                                                                                               metabolism  \\\n",
       "2083  Fostamatinib is metabolized in the gut by alkaline phosphatase to the active metabolite R406 Lab...   \n",
       "\n",
       "                                                               half_life  \\\n",
       "2083  R406 has a half-life of elimination of approximately 15 h 6,Label.   \n",
       "\n",
       "                                                                                                clearance  \\\n",
       "2083  Category: A, Protein: Tyrosine-protein kinase SYK, Actions: inhibitor | Category: U, Protein: Ad...   \n",
       "\n",
       "     metabolism_pathway action_pathway        UNII          CAS  approved_drug  \n",
       "2083      Not Available  Not Available  SQ8A3S5101  901119-35-5              1  "
      ]
     },
     "execution_count": 142,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_info_df[drug_info_df['target'].str.len() == 24879].head(2)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0c75c9db-d538-40bb-893a-29a43db666eb",
   "metadata": {},
   "source": [
    "## Scraping Pathways from SMPDB\n",
    "### Metabolism Pathways"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 159,
   "id": "dcb87075-141f-442d-864c-42d42c858892",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_pathway(url_link, verbose=False):\n",
    "    \"\"\"Parse drug pathway data from smpdc.ca website\"\"\"\n",
    "    # Send GET request\n",
    "    response = requests.get(url_link)\n",
    "\n",
    "    if response.status_code == 200:\n",
    "        # parse the content as HTML\n",
    "        try:\n",
    "            soup = BeautifulSoup(response.content, \"html.parser\")\n",
    "            # print(soup.prettify())\n",
    "\n",
    "        except:\n",
    "            print('Could not find drug information for', url_link)\n",
    "            soup = None\n",
    "\n",
    "        if soup:\n",
    "            path_way = soup.find('div', id='des_content')\n",
    "            if path_way:\n",
    "                path_way_text = path_way.find_all('div')[-1].text.strip().replace('\\n', ' ')\n",
    "            else:\n",
    "                path_way_text = \"Not Available\"\n",
    "            if verbose:\n",
    "                print(path_way_text)\n",
    "            return path_way_text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 150,
   "id": "2bc6ff6a-eeea-4d8b-9d9c-b52dbc9de934",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total metabolism pathway found: 71\n",
      "http://smpdb.ca/view/SMP0000597?highlight[compounds][]=DB00178&highlight[proteins][]=DB00178\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "\"Ramipril (trade name: Altace) belongs to the class of drugs known as angiotensin-converting enzyme (ACE) inhibitors and is used primarily to lower high blood pressure (hypertension). This drug can also be used in the treatment of congestive heart failure and type II diabetes. Ramipril is a prodrug which, following oral administration, undergoes biotransformation in vivo into its active form ramiprilat via cleavage of its ester group by the liver. Angiotensin-converting enzyme (ACE) is a component of the body's renin–angiotensin–aldosterone system (RAAS) and cleaves inactive angiotensin I into the active vasoconstrictor angiotensin II. ACE (or kininase II) also degrades the potent vasodilator bradykinin. Consequently, ACE inhibitors decrease angiotensin II concentrations and increase bradykinin concentrations resulting in blood vessel dilation and thereby lowering blood pressure.\""
      ]
     },
     "execution_count": 150,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metabolism_urls = drug_info_df[drug_info_df[\"metabolism_pathway\"] != \"Not Available\"][\"metabolism_pathway\"].values\n",
    "print('Total metabolism pathway found:', len(metabolism_urls))\n",
    "\n",
    "# test scraping pathway\n",
    "url_link = metabolism_urls[0]\n",
    "print(url_link)\n",
    "get_pathway(url_link)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 153,
   "id": "23dac7f8-b6fe-46b2-a082-96037f82133e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Scraping 0 to 5 Metabolism Pathway...\n",
      "Scraping 5 to 10 Metabolism Pathway...\n",
      "Scraping 10 to 15 Metabolism Pathway...\n",
      "Scraping 15 to 20 Metabolism Pathway...\n",
      "Scraping 20 to 25 Metabolism Pathway...\n",
      "Scraping 25 to 30 Metabolism Pathway...\n",
      "Scraping 30 to 35 Metabolism Pathway...\n",
      "Scraping 35 to 40 Metabolism Pathway...\n",
      "Scraping 40 to 45 Metabolism Pathway...\n",
      "Scraping 45 to 50 Metabolism Pathway...\n",
      "Scraping 50 to 55 Metabolism Pathway...\n",
      "Scraping 55 to 60 Metabolism Pathway...\n",
      "Scraping 60 to 65 Metabolism Pathway...\n",
      "Scraping 65 to 70 Metabolism Pathway...\n",
      "Scraping 70 to 75 Metabolism Pathway...\n"
     ]
    }
   ],
   "source": [
    "metabolism_pathways = []\n",
    "\n",
    "i = 0\n",
    "for url_link in metabolism_urls:\n",
    "    if i % 5 == 0:\n",
    "        print(f'Scraping {i} to {i+5} Metabolism Pathway...')\n",
    "    text = get_pathway(url_link)\n",
    "    pathway = (url_link, text)\n",
    "    i += 1\n",
    "\n",
    "    if pathway:\n",
    "        metabolism_pathways.append(pathway)\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 154,
   "id": "bb437e65-32fc-4c7e-b990-8d90323ba383",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Metabolism Pathway Dimension: (71, 2)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>url</th>\n",
       "      <th>metabolism_pathway</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>http://smpdb.ca/view/SMP0000597?highlight[compounds][]=DB00178&amp;highlight[proteins][]=DB00178</td>\n",
       "      <td>Ramipril (trade name: Altace) belongs to the class of drugs known as angiotensin-converting enzy...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>http://smpdb.ca/view/SMP0000628?highlight[compounds][]=DB00184&amp;highlight[proteins][]=DB00184</td>\n",
       "      <td>Nicotine is a stimulant drug that acts as an agonist at nicotinic acetylcholine receptors. These...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>http://smpdb.ca/view/SMP0000637?highlight[compounds][]=DB00193&amp;highlight[proteins][]=DB00193</td>\n",
       "      <td>Tramadol (also named Ultram) is a class of opioid pain medication that used for treating pain. M...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>http://smpdb.ca/view/SMP0000611?highlight[compounds][]=DB00208&amp;highlight[proteins][]=DB00208</td>\n",
       "      <td>Ticlopidine, marketed as Ticlid, is an antiplatelet drug that targets the P2Y12 receptor of plat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>http://smpdb.ca/view/SMP0000615?highlight[compounds][]=DB00213&amp;highlight[proteins][]=DB00213</td>\n",
       "      <td>Pantoprazole is a proton pump inhibitor (PPI) class drug that suppresses the final step in gastr...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                            url  \\\n",
       "0  http://smpdb.ca/view/SMP0000597?highlight[compounds][]=DB00178&highlight[proteins][]=DB00178   \n",
       "1  http://smpdb.ca/view/SMP0000628?highlight[compounds][]=DB00184&highlight[proteins][]=DB00184   \n",
       "2  http://smpdb.ca/view/SMP0000637?highlight[compounds][]=DB00193&highlight[proteins][]=DB00193   \n",
       "3  http://smpdb.ca/view/SMP0000611?highlight[compounds][]=DB00208&highlight[proteins][]=DB00208   \n",
       "4  http://smpdb.ca/view/SMP0000615?highlight[compounds][]=DB00213&highlight[proteins][]=DB00213   \n",
       "\n",
       "                                                                                    metabolism_pathway  \n",
       "0  Ramipril (trade name: Altace) belongs to the class of drugs known as angiotensin-converting enzy...  \n",
       "1  Nicotine is a stimulant drug that acts as an agonist at nicotinic acetylcholine receptors. These...  \n",
       "2  Tramadol (also named Ultram) is a class of opioid pain medication that used for treating pain. M...  \n",
       "3  Ticlopidine, marketed as Ticlid, is an antiplatelet drug that targets the P2Y12 receptor of plat...  \n",
       "4  Pantoprazole is a proton pump inhibitor (PPI) class drug that suppresses the final step in gastr...  "
      ]
     },
     "execution_count": 154,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metabolism_pathway_df = pd.DataFrame(metabolism_pathways, columns=['url', 'metabolism_pathway'])\n",
    "metabolism_pathway_df = metabolism_pathway_df.drop_duplicates()\n",
    "\n",
    "print('Metabolism Pathway Dimension:', metabolism_pathway_df.shape)\n",
    "metabolism_pathway_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 155,
   "id": "2c8606db-ea8e-4741-849b-a6c0c375a671",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save data\n",
    "metabolism_pathway_df.to_csv(\"data/scraping_metabolism_pathways.csv\", index=False, sep='\\t')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ebe85aff-0bff-42bf-a81d-d9d638a2bd0f",
   "metadata": {},
   "source": [
    "### Action Pathways"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 157,
   "id": "4c7eeb67-ae34-4233-a4c3-bca6a87047ee",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total action pathway found: 381\n",
      "http://smpdb.ca/view/SMP0000277?highlight[compounds][]=DB00006&highlight[proteins][]=DB00006\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'Bivalirudin, trade name angiomax, is a direct thrombin inhibitor. It is often prescribed to patients who cannot take unfractionated or low molecular weight heparin. Bivalirudin does not need cofactor antithrobin to act. It binds circulating and clot-bound thrombin at the catalytic site and the anion binding exosite. The inhibition of fibrin prevents the cleavage of fibrinogen into fibrin which activates Factor XIII and Factor XIIIa. This destabilizes the thrombus and inhibits the promotion of thrombin production and platelet activation. As a result, bivalirudin prevents or reduces clot formation.'"
      ]
     },
     "execution_count": 157,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "action_urls = drug_info_df[drug_info_df[\"action_pathway\"] != \"Not Available\"][\"action_pathway\"].values\n",
    "print('Total action pathway found:', len(action_urls))\n",
    "\n",
    "# test scraping pathway\n",
    "url_link = action_urls[0]\n",
    "print(url_link)\n",
    "get_pathway(url_link)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 160,
   "id": "86e1ffc1-e50a-41fb-896c-83bbab499cd4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Scraping 0 to 5 Action Pathways...\n",
      "Scraping 5 to 10 Action Pathways...\n",
      "Scraping 10 to 15 Action Pathways...\n",
      "Scraping 15 to 20 Action Pathways...\n",
      "Scraping 20 to 25 Action Pathways...\n",
      "Scraping 25 to 30 Action Pathways...\n",
      "Scraping 30 to 35 Action Pathways...\n",
      "Scraping 35 to 40 Action Pathways...\n",
      "Scraping 40 to 45 Action Pathways...\n",
      "Scraping 45 to 50 Action Pathways...\n",
      "Scraping 50 to 55 Action Pathways...\n",
      "Scraping 55 to 60 Action Pathways...\n",
      "Scraping 60 to 65 Action Pathways...\n",
      "Scraping 65 to 70 Action Pathways...\n",
      "Scraping 70 to 75 Action Pathways...\n",
      "Scraping 75 to 80 Action Pathways...\n",
      "Scraping 80 to 85 Action Pathways...\n",
      "Scraping 85 to 90 Action Pathways...\n",
      "Scraping 90 to 95 Action Pathways...\n",
      "Scraping 95 to 100 Action Pathways...\n",
      "Scraping 100 to 105 Action Pathways...\n",
      "Scraping 105 to 110 Action Pathways...\n",
      "Scraping 110 to 115 Action Pathways...\n",
      "Scraping 115 to 120 Action Pathways...\n",
      "Scraping 120 to 125 Action Pathways...\n",
      "Scraping 125 to 130 Action Pathways...\n",
      "Scraping 130 to 135 Action Pathways...\n",
      "Scraping 135 to 140 Action Pathways...\n",
      "Scraping 140 to 145 Action Pathways...\n",
      "Scraping 145 to 150 Action Pathways...\n",
      "Scraping 150 to 155 Action Pathways...\n",
      "Scraping 155 to 160 Action Pathways...\n",
      "Scraping 160 to 165 Action Pathways...\n",
      "Scraping 165 to 170 Action Pathways...\n",
      "Scraping 170 to 175 Action Pathways...\n",
      "Scraping 175 to 180 Action Pathways...\n",
      "Scraping 180 to 185 Action Pathways...\n",
      "Scraping 185 to 190 Action Pathways...\n",
      "Scraping 190 to 195 Action Pathways...\n",
      "Scraping 195 to 200 Action Pathways...\n",
      "Scraping 200 to 205 Action Pathways...\n",
      "Scraping 205 to 210 Action Pathways...\n",
      "Scraping 210 to 215 Action Pathways...\n",
      "Scraping 215 to 220 Action Pathways...\n",
      "Scraping 220 to 225 Action Pathways...\n",
      "Scraping 225 to 230 Action Pathways...\n",
      "Scraping 230 to 235 Action Pathways...\n",
      "Scraping 235 to 240 Action Pathways...\n",
      "Scraping 240 to 245 Action Pathways...\n",
      "Scraping 245 to 250 Action Pathways...\n",
      "Scraping 250 to 255 Action Pathways...\n",
      "Scraping 255 to 260 Action Pathways...\n",
      "Scraping 260 to 265 Action Pathways...\n",
      "Scraping 265 to 270 Action Pathways...\n",
      "Scraping 270 to 275 Action Pathways...\n",
      "Scraping 275 to 280 Action Pathways...\n",
      "Scraping 280 to 285 Action Pathways...\n",
      "Scraping 285 to 290 Action Pathways...\n",
      "Scraping 290 to 295 Action Pathways...\n",
      "Scraping 295 to 300 Action Pathways...\n",
      "Scraping 300 to 305 Action Pathways...\n",
      "Scraping 305 to 310 Action Pathways...\n",
      "Scraping 310 to 315 Action Pathways...\n",
      "Scraping 315 to 320 Action Pathways...\n",
      "Scraping 320 to 325 Action Pathways...\n",
      "Scraping 325 to 330 Action Pathways...\n",
      "Scraping 330 to 335 Action Pathways...\n",
      "Scraping 335 to 340 Action Pathways...\n",
      "Scraping 340 to 345 Action Pathways...\n",
      "Scraping 345 to 350 Action Pathways...\n",
      "Scraping 350 to 355 Action Pathways...\n",
      "Scraping 355 to 360 Action Pathways...\n",
      "Scraping 360 to 365 Action Pathways...\n",
      "Scraping 365 to 370 Action Pathways...\n",
      "Scraping 370 to 375 Action Pathways...\n",
      "Scraping 375 to 380 Action Pathways...\n",
      "Scraping 380 to 385 Action Pathways...\n"
     ]
    }
   ],
   "source": [
    "action_pathways = []\n",
    "\n",
    "i = 0\n",
    "for url_link in action_urls:\n",
    "    if i % 5 == 0:\n",
    "        print(f'Scraping {i} to {i+5} Action Pathways...')\n",
    "    text = get_pathway(url_link)\n",
    "    pathway = (url_link, text)\n",
    "    i += 1\n",
    "\n",
    "    if pathway:\n",
    "        action_pathways.append(pathway)\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 161,
   "id": "9d8ca2ef-2125-464c-b9b4-c794c93979e8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Action Pathway Dimension: (381, 2)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>url</th>\n",
       "      <th>action_pathway</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>http://smpdb.ca/view/SMP0000277?highlight[compounds][]=DB00006&amp;highlight[proteins][]=DB00006</td>\n",
       "      <td>Bivalirudin, trade name angiomax, is a direct thrombin inhibitor. It is often prescribed to pati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>http://smpdb.ca/view/SMP0000429?highlight[compounds][]=DB00118&amp;highlight[proteins][]=DB00118</td>\n",
       "      <td>Disulfiram is a drug used in the treatment of cocaine addiction and chronic alcoholism. With reg...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>http://smpdb.ca/view/SMP0000429?highlight[compounds][]=DB00126&amp;highlight[proteins][]=DB00126</td>\n",
       "      <td>Disulfiram is a drug used in the treatment of cocaine addiction and chronic alcoholism. With reg...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>http://smpdb.ca/view/SMP0000428?highlight[compounds][]=DB00130&amp;highlight[proteins][]=DB00130</td>\n",
       "      <td>Mercaptopurine is a purine antimetabolite prodrug that exerts cytotoxic effects via three mechan...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>http://smpdb.ca/view/SMP0000729?highlight[compounds][]=DB00134&amp;highlight[proteins][]=DB00134</td>\n",
       "      <td>Chloramphenicol, trade names Pentamycetin and Chloromycetin, is a broad spectrum antibiotic orig...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                            url  \\\n",
       "0  http://smpdb.ca/view/SMP0000277?highlight[compounds][]=DB00006&highlight[proteins][]=DB00006   \n",
       "1  http://smpdb.ca/view/SMP0000429?highlight[compounds][]=DB00118&highlight[proteins][]=DB00118   \n",
       "2  http://smpdb.ca/view/SMP0000429?highlight[compounds][]=DB00126&highlight[proteins][]=DB00126   \n",
       "3  http://smpdb.ca/view/SMP0000428?highlight[compounds][]=DB00130&highlight[proteins][]=DB00130   \n",
       "4  http://smpdb.ca/view/SMP0000729?highlight[compounds][]=DB00134&highlight[proteins][]=DB00134   \n",
       "\n",
       "                                                                                        action_pathway  \n",
       "0  Bivalirudin, trade name angiomax, is a direct thrombin inhibitor. It is often prescribed to pati...  \n",
       "1  Disulfiram is a drug used in the treatment of cocaine addiction and chronic alcoholism. With reg...  \n",
       "2  Disulfiram is a drug used in the treatment of cocaine addiction and chronic alcoholism. With reg...  \n",
       "3  Mercaptopurine is a purine antimetabolite prodrug that exerts cytotoxic effects via three mechan...  \n",
       "4  Chloramphenicol, trade names Pentamycetin and Chloromycetin, is a broad spectrum antibiotic orig...  "
      ]
     },
     "execution_count": 161,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "action_pathway_df = pd.DataFrame(action_pathways, columns=['url', 'action_pathway'])\n",
    "action_pathway_df = action_pathway_df.drop_duplicates()\n",
    "\n",
    "print('Action Pathway Dimension:', action_pathway_df.shape)\n",
    "action_pathway_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 162,
   "id": "3068eb09-d09a-4311-86d3-dabd3cad4937",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save data\n",
    "action_pathway_df.to_csv(\"data/scraping_action_pathways.csv\", index=False, sep='\\t')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
